Replies to post #218182 on Biotech Values

[DewDiligence]

Given lack of buzz in this CC...I'm just going to keep VXRT on my radar for a while and don't have plans for any imminent position despite what seems like a pretty cheap valuation to me.

A reasonable decision, IMO, especially when you factor in the likelihood of a financing in the next few months.

[DewDiligence]

VXRT hires CCO:

https://finance.yahoo.com/news/vaxart-appoints-brant-biehn-senior-120000280.html

Seems a little premature.